
- /
- Supported exchanges
- / US
- / DNA.NYSE
Ginkgo Bioworks Holdings (DNA NYSE) stock market data APIs
Ginkgo Bioworks Holdings Financial Data Overview
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Ginkgo Bioworks Holdings data using free add-ons & libraries
Get Ginkgo Bioworks Holdings Fundamental Data
Ginkgo Bioworks Holdings Fundamental data includes:
- Net Revenue: 237 M
- EBITDA: -325 196 992
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-13
- EPS/Forecast: -0.08
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Ginkgo Bioworks Holdings News

Ginkgo Bioworks launches cost-effective ADME profiling service
BOSTON - Ginkgo Bioworks (NYSE:DNA), a biotechnology company with a robust balance sheet showing a current ratio of 4.88x, announced on Thursday the introduction of a new high-throughput ADME profilin...


Ginkgo Bioworks Holdings, Inc. (DNA) Outperforms Broader Market: What You Need to Know
Ginkgo Bioworks Holdings, Inc. (DNA) ended the recent trading session at $9.60, demonstrating a +1.8% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a ...

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Sinks As Market Gains: Here's Why
Ginkgo Bioworks Holdings, Inc. (DNA) ended the recent trading session at $10.79, demonstrating a -2.53% change from the preceding day's closing price. This move lagged the S&P 500's daily gain of 0.28...

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves 1.41%: What You Should Know
Ginkgo Bioworks Holdings, Inc. (DNA) closed the most recent trading day at $9.32, moving +1.41% from the previous trading session. Elsewhere, the Dow lost 0.25%, while the tech-heavy Nasdaq added 0.31...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.